10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014
	OR
[   ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 000-53949

HDS INTERNATIONAL CORP.

(Exact name of registrant as specified in its charter)

Nevada

(State of incorporation)

10 Dorrance Street, Suite 700

Providence, RI   02903

(Address of principal executive offices)

(401) 400-0028

(Registrant's telephone number)

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.   YES [X]     NO [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (SS 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

YES [X]     NO [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer, "accelerated filer," "non-accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer	[   ]	Accelerated Filer	[   ]
Non-accelerated Filer (Do not check if smaller reporting company)	[   ]	Smaller Reporting Company	[X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   YES [   ]     NO [X]

APPLICABLE ONLY TO CORPORATE ISSUERS:

As of May 1, 2014, there were 385,774,504 shares of the registrant's $0.001 par value common stock issued and outstanding.

HDS INTERNATIONAL CORP.

TABLE OF CONTENTS

		Page
PART I.   FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENTS.	3
	Consolidated Balance Sheets	3
	Consolidated Statements of Operations	4
	Consolidated Statements of Cash Flows	5
	Notes to the Consolidated Financial Statements	6
ITEM 2.	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	13
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	15
ITEM 4.	CONTROLS AND PROCEDURES.	15
PART II.   OTHER INFORMATION
ITEM 1A.	RISK FACTORS.	15
ITEM 6.	EXHIBITS.	16
Signatures		17
Exhibit Index		18

-2-

PART I - FINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS.

HDS International Corp.

(A Development Stage Company)

Consolidated Balance Sheets

(expressed in U.S. dollars)

	March 31, 2014 (unaudited) $			December 31, 2013 $
ASSETS
Current Assets
Cash		6,812			3,371
Current portion of deferred financing costs		3,379			–
Total Current Assets		10,191			3,371
Other Assets
Deferred financing costs		2,269			6,685
Total Assets		12,460			10,056
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable and accrued liabilities		517,325			449,022
Accounts payable and accrued liabilities – related parties		181,841			143,244
Due to related parties		300,000			300,000
Convertible debentures, net of unamortized discount of $48,180 and $28,384, respectively		11,820			4,116
Derivative liability		90,273			45,521
Total Current Liabilities		1,101,259			941,903
Non-Current Liabilities
Convertible debentures, net of unamortized discount of $45,066 and $55,603, respectively		2,934			4,397
Total Liabilities		1,104,193			946,300
Stockholders' Deficit
Preferred Stock Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share Issued and outstanding: nil preferred shares		–			–
Class A Preferred Stock Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share Issued and outstanding: 7,500,000 shares		7,500			7,500
Common Stock Authorized: 2,000,000,000 common shares, with a par value of $0.001 per share Issued and outstanding: 377,203,075 shares		377,203			377,203
Additional paid-in capital		397,275			381,775
Deficit accumulated during the development stage		(1,873,711	)		(1,702,722	)
Total Stockholders' Deficit		(1,091,733	)		(936,244	)
.
Total Liabilities and Stockholders' Deficit		12,460			10,056

(The accompanying notes are an integral part of these consolidated financial statements)

-3-

HDS International Corp.

(A Development Stage Company)

Consolidated Statements of Operations

(expressed in U.S. dollars)

(unaudited)

	For the Three Months Ended March 31, 2014 $			For the Three Months Ended March 31, 2013 $			Accumulated from November 3, 2008 (date of inception) to March 31, 2014 $
Revenue		–			–			–
Operating Expenses
Consulting fees		96,000			111,750			1,108,750
General and administrative		1,760			2,661			105,610
Management fees		–			–			43,727
Professional fees		11,100			9,500			238,601
Transfer agent fees		–			169			18,868
Total Operating Expenses		108,860			124,080			1,515,556
Income (Loss) Before Other Expenses		(108,860	)		(124,080	)		(1,515,556	)
Other Expenses (Income)
Accretion expense		–			–			16,800
Impairment of intangible assets		–			–			92,538
Interest expense		17,377			7,397			139,626
Loss on change in fair value of derivative liability		44,752			–			90,273
Loss (gain) on settlement of debt		–			–			18,918
Total Other Expenses (Income)		62,129			7,397			358,155
Net Income (Loss)		(170,989	)		(131,477	)		(1,873,711	)
Net Income (Loss) Per Share, Basic and Diluted		(0.00	)		(0.00	)
Weighted Average Shares Outstanding		377,203,075			377,189,745

(The accompanying notes are an integral part of these consolidated financial statements)

-4-

HDS International Corp.

(A Development Stage Company)

Consolidated Statements of Cash Flows

(expressed in U.S. dollars)

(unaudited)

	For the Three Months Ended March 31, 2014 $			For the Three Months Ended March 31, 2013 $			Accumulated from November 3, 2008 (date of inception) to March 31, 2014 $
Operating Activities
Net income (loss)		(170,989	)		(131,477	)		(1,873,711	)
Adjustment to reconcile net loss to net cash used in operating activities:
Accretion of debt discount		6,241			–			31,554
Amortization of deferred financing costs		1,537			–			4,352
Impairment of intangible assets		–			–			92,538
Loss on change in fair value of derivative liability		44,752			–			90,273
Loss on settlement of debt		–			–			18,918
Shares issued for management and consulting fees		–			6,000			13,000
Stock-based compensation		–			–			2,227
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities		68,303			81,154			564,932
Accounts payable and accrued liabilities – related parties		37,397			31,597			169,616
Due to related parties		–			–			11,965
Net Cash Used in Operating Activities		(12,759	)		(12,726	)		(874,336	)
Investing activities
Acquisition of intangible assets		–			–			(10,000	)
Net Cash Provided (Used) by Investing Activities		–			–			(10,000	)
Financing activities
Bank overdraft		–			76			–
Proceeds from convertible debenture, net of financing costs		15,000			–			98,000
Proceeds from loan payable		–			–			709,600
Repayments of loan payable		–			–			(149,449	)
Proceeds from related parties		1,200			–			14,874
Repayments to related parties		–			–			(25,000	)
Capital contribution		–			–			200,600
Proceeds from the issuance of common stock		–			–			42,523
Net Cash Provided by Financing Activities		16,200			76			891,148
Change in Cash		3,441			(12,650	)		6,812
Cash, Beginning of Period		3,371			12,650			–
Cash, End of Period		6,812			–			6,812
Supplemental Disclosures
Interest paid		–			–			–
Income tax paid		–			–			–
Non-cash investing and financing activities
Debt discount due to beneficial conversion feature		15,500			–			108,000
Forgiveness of related party debt		–			–			2,649
Issuance of common shares to settle debt		–			–			580,055
Issuance of common shares for acquisition of assets		–			–			250,000
Issuance of preferred shares for acquisition of assets		–			–			7,500
Issuance of note payable for acquisition of assets		–			–			325,000

(The accompanying notes are an integral part of these consolidated financial statements)

-5-

HDS International Corp.

(A Development Stage Company)

Notes to the Consolidated Financial Statements

(expressed in U.S. dollars)

1.  Nature of Operations and Continuance of Business

HDS International Corp. (the "Company") was incorporated on November 3, 2008 under the laws of the State of Nevada. The Company plans to engage in the business of providing renewable energy and eco-sustainability solutions based on its licensed technologies. A substantial portion of the Company's activities has involved developing a business plan and establishing contacts and visibility in the marketplace and the Company has not generated any revenue to date.  

On June 11, 2012, HDS Energy and Ecosystems NB, Ltd., the Company's wholly owned subsidiary, was incorporated in the Province of New Brunswick, Canada to manage the operations and other business development efforts.

Going Concern

These consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has generated no revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future.  As of March 31, 2014, the Company had a working capital deficiency of $1,091,068 and an accumulated deficit of $1,873,711. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's future business. These factors raise substantial doubt regarding the Company's ability to continue as a going concern. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. 

2.Summary of Significant Accounting Policies

a)Principles of Consolidation

The consolidated financial statements financial statements for the periods ended March 31, 2014 and December 31, 2013 include the accounts of HDS International Corp. and HDS Energy and Ecosystems NB, Ltd., the Company's wholly owned subsidiary effective June 11, 2012. All intercompany transactions have been eliminated in consolidation.

b)Basis of Presentation

These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in US dollars. The Company's fiscal year-end is December 31.

c)Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States and requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to stock-based compensation and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company's estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

d)Cash and Cash Equivalents

The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. As of March 31, 2014 and December 31, 2013, the Company had no cash equivalents.

e)Intangible Assets

Intangible assets are carried at the purchased cost less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets, generally from fifteen to twenty years.

-6-

HDS International Corp.

(A Development Stage Company)

Notes to the Consolidated Financial Statements

(expressed in U.S. dollars)

2.  Summary of Significant Accounting Policies (continued)

f)Impairment of Long-Lived Assets

Long-lived assets and certain identifiable intangible assets to be held and used are reviewed for impairment whenever events or changes in circumstance indicate that the carrying amount of such assets may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. Measurement of an impairment loss for long-lived assets and certain identifiable intangible assets that management expects to hold and use is based on the fair value of the asset. Long-lived assets and certain identifiable intangible assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

g)Beneficial Conversion Features

From time to time, the Company may issue convertible notes that may contain an imbedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.

h)Derivative Liability

From time to time, the Company may issue equity instruments that may contain an embedded derivative instrument which may result in a derivative liability. A derivative liability exists on the date the equity instrument is issued when there is a contingent exercise provision. The derivative liability is records at is fair value calculated by using an option pricing model such as a multi-nominal lattice model. The fair value of the derivative liability is then calculated on each balance sheet date with the corresponding gains and losses recorded in the consolidated statement of operations

i)Development Stage Company

The Company is currently considered a development stage company as defined by ASC 915-10-05. As a development stage enterprise, the Company discloses the deficit accumulated during the development stage and the cumulative statements of operations and cash flows from inception to the current balance sheet date. An entity remains in the development stage until such time as, among other factors, revenues have been realized. To date, the development stage of the Company's operations consists of developing the business model and marketing concepts.

j)   Basic and Diluted Net Loss Per Share

The Company computes net loss per share in accordance with ASC 260, Earnings Per Share, which requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At March 31, 2013, the Company had 95,238,095 (December 31, 2013 – 51,166,667) potentially dilutive shares from outstanding convertible debentures.

k)Interim Consolidated Financial Statements

These interim unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company's financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period.

-7-

HDS International Corp.

(A Development Stage Company)

Notes to the Consolidated Financial Statements

(expressed in U.S. dollars)

2.Summary of Significant Accounting Policies (continued)

l)Income Taxes

Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740, Income Taxes, as of its inception. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.

m)Comprehensive Loss

ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at March 31, 2014 and December 31, 2013, the Company has no items that represent comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements.

n)Financial Instruments

ASC 820, "Fair Value Measurements", requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Assets and liabilities measured at fair value on a recurring basis were presented on the Company's balance sheet as at March 31, 2014 and December 31, 2013 as follows:

	Balance, December 31, 2013 $		New Issuances $		Changes in Fair Values $			Balance, March 31, 2014 $
Convertible debenture		8,513		15,500		(9,259	)		14,754
Derivative Liability		45,521		–		44,752			90,273
		54,034		15,500		35,493			105,027

The carrying values of all of our other financial instruments, which include accounts payable and accrued liabilities, and amounts due to related parties approximate their current fair values because of their nature and respective maturity dates or durations.

-8-

HDS International Corp.

(A Development Stage Company)

Notes to the Consolidated Financial Statements

(expressed in U.S. dollars)

2.Summary of Significant Accounting Policies (continued)

o)Recent Accounting Pronouncements

In July 2013, FASB issued ASU No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists." The provisions of ASU No. 2013-11 require an entity to present an unrecognized tax benefit, or portion thereof, in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward, with certain exceptions related to availability. ASU No. 2013 11 is effective for interim and annual reporting periods beginning after December 15, 2013. The adoption of ASU No. 2013-11 did not have a material impact on the Company's consolidated financial statementsIn August 2012, the FASB issued ASU 2012-03, "Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update)" in Accounting Standards Update No. 2012-03. This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 is not expected to have a material impact on our financial position or results of operations.

The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). The amendments are effective for reporting periods beginning after December 15, 2012, for public companies. Early adoption is permitted. The adoption of ASU No. 2013-02 did not have a material impact on the Company's consolidated financial statements.

In January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like ASU 2011-11, the amendments in this update will be effective for fiscal periods beginning on, or after January 1, 2013. The adoption of ASU 2013-01 did not have a material impact on the Company's consolidated financial statements.

The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

3.  Convertible Debentures

a) On June 7, 2013, the Company entered into a $32,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on December 7, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (December 4, 2013) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company's common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2014, the Company recorded accrued interest of $2,116 (December, 31, 2013 - $1,475), which has been included in accounts payable and accrued liabilities.

In accordance with ASC 470-20, "Debt with Conversion and Other Options", the Company recognized the intrinsic value of the embedded beneficial conversion feature of $32,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2014, the Company had amortized $2,947 (December, 31, 2013 - $4,116) of the debt discount to interest expense. As at March 31, 2014, the carrying value of the debenture was $7,063 (December, 31, 2013 - $4,116).

On December 4, 2013, the note became convertible resulting in the Company recording a derivative liability of $46,532 with a corresponding adjustment to loss on change in fair value of derivative liabilities. As at March 31, 2014, the Company revalued the derivative liability to its fair value resulting in the Company recording $3,504 (December 31, 2013 - $1,011) as gain on change in fair value of derivative liabilities. As at March 31, 2014, the fair value of the derivative liability was $49,025 (December, 31, 2013 - $45,521). Refer to Note 4.

-9-

HDS International Corp.

(A Development Stage Company)

Notes to the Consolidated Financial Statements

(expressed in U.S. dollars)

3.Convertible Debentures (continued)

b) On July 15, 2013, the Company entered into a $27,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on January 11, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (January 11, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company's common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2014, the Company recorded accrued interest of $1,561 (December, 31, 2013 - $1,019), which has been included in accounts payable and accrued liabilities.

In accordance with ASC 470-20, "Debt with Conversion and Other Options", the Company recognized the intrinsic value of the embedded beneficial conversion feature of $27,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2014, the Company had amortized $1,978 (December, 31, 2013 - $2,779) of the debt discount to interest expense. As at March 31, 2014, the carrying value of the debenture was $4,757 (December, 31, 2013 - $2,779).

On January 11, 2014, the note became convertible resulting in the Company recording a derivative liability of $36,272 with a corresponding adjustment to loss on change in fair value of derivative liabilities. As at March 31, 2014, the Company revalued the derivative liability to its fair value resulting in the Company recording $4,976 (December 31, 2013 - $nil) as gain on change in fair value of derivative liabilities. As at March 31, 2014, the fair value of the derivative liability was $41,248 (December, 31, 2013 - $nil). Refer to Note 4.

c) On October 4, 2013, the Company entered into a $32,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on July 8, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (April 2, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company's common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2014, the Company recorded accrued interest of $1,268 (December, 31, 2013 - $627), which has been included in accounts payable and accrued liabilities.

In accordance with ASC 470-20, "Debt with Conversion and Other Options", the Company recognized the intrinsic value of the embedded beneficial conversion feature of $32,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2014, the Company had amortized $1,024 (December, 31, 2013 - $1,618) of the debt discount to interest expense. As at March 31, 2014, the carrying value of the debenture was $2,642 (December, 31, 2013 - $1,618)

As the note does not become convertible until April 2, 2014, the Company has not yet recognized any derivative liability associated with this note.

d) On February 18, 2014, the Company entered into a $15,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on August 20, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (August 17, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company's common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2014, the Company recorded accrued interest of $139 (December, 31, 2013 - $nil), which has been included in accounts payable and accrued liabilities.

In accordance with ASC 470-20, "Debt with Conversion and Other Options", the Company recognized the intrinsic value of the embedded beneficial conversion feature of $15,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2014, the Company had amortized $292 (December, 31, 2013 - $nil) of the debt discount to interest expense. As at March 31, 2014, the carrying value of the debenture was $292 (December, 31, 2013 - $nil).

As the note does not become convertible until August 17, 2014, the Company has not yet recognized any derivative liability associated with this note.

-10-

HDS International Corp.

(A Development Stage Company)

Notes to the Consolidated Financial Statements

(expressed in U.S. dollars)

4.  Derivative Liabilities

The Company records the fair value of the of the conversion price of the convertible debentures disclosed in Notes 3(a) and 3(b) in accordance with ASC 815, Derivatives and Hedging. The fair value of the derivative was calculated using a multi-nominal lattice model performed by an independent qualified business valuator. The fair value of the derivative liability is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statement of operations. During the period ended March 31, 2014, the Company recorded a loss on the change in fair value of derivative liability of $44,752 (December, 31, 2013 - $45,521). As at March 31, 2014, the Company recorded a derivative liability of $90,273 (December, 31, 2013 - $45,521).

The following inputs and assumptions were used to value the convertible debentures outstanding during the period ended March 31, 2014:

· The underlying stock price of $0.0014 was used as the fair value of the common stock as at December 31, 2013.

· The underlying stock price of $0.0033 was used as the fair value of the common stock as at March 31, 2014.

· The principal of the debenture on the June 7, 2013 date of issuance was $32,500.

· The balance of the principal and interest of the June 7, 2013 debenture on December 4, 2013, the date the June 7, 2013 debenture became convertible, was $33,775.

· The balance of the principal and interest of the June 7, 2013 debenture on December 31, 2013 was $33,975.

· The balance of the principal and interest of the June 7, 2013 debenture on March 31, 2014 was $34,616.

· The principal of the debenture on the July 15, 2013 date of issuance was $27,500.

· The balance of the principal and interest of the July 15, 2013 debenture on January 11, 2014, the date the July 15, 2013 debenture became convertible, was $28,579.

· The balance of the principal and interest of the July 15, 2013 debenture on March 31, 2014 was $29,061

· Capital raising events are not a factor for the debenture.

· The Holder would redeem based on availability of alternative financing 0% of the time increasing 1.0% monthly to a maximum of 10%.

· The Holder would automatically convert the note at maturity if the registration (after 120 days) was effective and the Company is not in default.

· The projected annual volatility for each valuation period was based on the historic volatility of the Company of 178% as at December 4, 2013, 176% as at December 31, 2013, 175% as at January 11, 2014 and 171% as at March 31, 2014

· An event of default would occur 0% of the time, increasing to 1.0% per month to a maximum of 5%. To date, the debenture is not in default nor converted by the Holder.

A summary of the activity of the derivative liability is shown below:

	$
Balance, December 31, 2012		–
Derivative loss due to new issuances		46,532
Mark to market adjustment at December 31, 2013		(1,011	)
Balance, December 31, 2013		45,521
Derivative loss due to new issuances		36,272
Mark to market adjustment at March 31, 2014		8,480
Balance, March 31, 2014		90,273

5.Related Party Transactions

a) As at March 31, 2014, the Company owes $300,000 (December 31, 2013 - $300,000) to a company controlled by officers and directors of the Company.  The amount owing is unsecured, bears interest at 10% per annum, and is due on demand.  As at March 31, 2014, the Company has recorded accrued interest of $79,616 (December 31, 2013 - $72,219) which has been included in accounts payable and accrued liabilities – related party.

b) As at March 31, 2014, the Company owes $10,225 (December 31, 2013 - $10,225) to companies under common control by officers and directors of the Company which has been included in accounts payable and accrued liabilities – related parties. The amounts owing are unsecured, non-interest bearing, and due on demand.

-11-

HDS International Corp.

(A Development Stage Company)

Notes to the Consolidated Financial Statements

(expressed in U.S. dollars)

5.Related Party Transactions (continued)

c) During the period ended March 31, 2014, the Company has incurred $30,000 (December 31, 2013 - $45,000) to the President and CEO of the Company for consulting services. As at March 31, 2014, the Company recorded a related party accounts payable of $90,000 (December 31, 2013 - $60,000), which has been included in accounts payable and accrued liabilities – related party. The amounts owing are unsecured, non-interest bearing, and due on demand.

d) As at March 31, 2014, the Company owes $2,000 (December 31, 2013 – $800) to the President and CEO of the Company for reimbursement of expenses which has been included in accounts payable and accrued liabilities – related parties.  The amount owing is unsecured, non-interest bearing, and due on demand.

6.Commitments

a) On October 12, 2011, the Company entered into a verbal consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On July 18, 2012, the Board of Directors reviewed the consulting agreement and authorized an increase to the monthly consulting fee from $3,000 to $3,750 per month beginning July 2012. On October 1, 2012, the Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,750 to $3,000 per month beginning October 2012. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,000 to $500 per month effective January 1, 2014.

During the period ended March 31, 2014, the Company incurred $1,500 (December 31, 2013 - $36,000) in consulting fees relating to this agreement, of which $43,500 (December 31, 2013 - $42,000) has been recorded in accounts payable and accrued liabilities as at March 31, 2014.

b) On October 12, 2011, the Company entered into a consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $27,500. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $27,500 to $21,500 per month effective January 1, 2014.

During the year ended March 31, 2014, the Company incurred $64,500 (December 31, 2013 - $330,000) in consulting fees relating to this agreement, of which $448,000 (December 31, 2013 - $383,500) has been recorded in accounts payable and accrued liabilities as at March 31, 2014.

c) On October 12, 2011, the Company entered into a consulting agreement with the President and CEO of the Company whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On June 10, 2012, the Board of Directors authorized an increase to the monthly consulting fee from $3,000 to $6,000 per month beginning June 2012. On July 18, 2012, the Board of Directors reviewed the consulting agreement and adjusted the monthly consulting fee to $3,750 beginning July 2012. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,750 to $10,000 per month effective January 1, 2014.

During the year ended March 31, 2014, the Company incurred $30,000 (December 31, 2013 - $45,000) in consulting fees relating to this agreement, of which $90,000 (December 31, 2013 - $60,000) has been recorded in accounts payable and accrued liabilities – related parties as at March 31, 2014.

d) On January 2, 2013, the Company entered into a consulting agreement with The Holden Group, LLC ("Holden") whereby the Company paid Holden $2,000 and issued 600,000 restricted common shares of the Company upon the execution of the agreement as well as pay $500 on each of the first, second and third month anniversaries of the agreement. These final three payments have been accrued and recorded in accounts payable and accrued liabilities.

7.Subsequent Event

On April 9, 2014, the Company issued 8,571,429 common shares for the conversion of $12,000 of the convertible debenture, as noted in Note 3(a).

-12-

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF OPERATION.

Forward Looking Statements

This Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) contains forward-looking statements that involve known and unknown risks, significant uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, or implied, by those forward-looking statements.  You can identify forward-looking statements by the use of the words may, will, should, could, expects, plans, anticipates, believes, estimates, predicts, intends, potential, proposed, or continue or the negative of those terms.  These statements are only predictions. In evaluating these statements, you should consider various factors which may cause our actual results to differ materially from any forward-looking statements.  Although we believe that the exceptions reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.  Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements.  We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

We are considered a start-up corporation.  Our auditors have issued a going concern opinion on the financial statements for the year ended December 31, 2013.

RESULTS OF OPERATIONS

Working Capital

	March 31, 2014 $			December 31, 2013 $
Current Assets		10,191			3,371
Current Liabilities		1,101,259			941,903
Working Capital (Deficit)		(1,091,068	)		(938,532	)

Cash Flows

	March 31, 2014 $			March 31, 2013 $
Cash Flows from (used in) Operating Activities		(12,759	)		(12,726	)
Cash Flows from (used in) Financing Activities		–			–
Net Increase (decrease) in Cash During Period		16,200			76

Operating Revenues

We have not generated any revenues since inception.

Operating Expenses and Net Loss

Operating expenses for the three months ended March 31, 2014 were $108,860 compared with $124,080 for the three months ended March 31, 2013. The decrease in operating expenses was attributed to a decrease in consulting fees of $15,750, transfer agent fees of $169 and general and administrative fees of $901 for day-to-day operating costs offset by an increase in professional fees of $1,600.

During the three months ended March 31, 2014, the Company recorded a net loss of $170,989 compared with net loss of $131,477 for the three months ended March 31, 2013. In addition to the above, the Company incurred an increase of $9,980 of interest expense relating to debt balances and $44,752 for loss on the change in fair value of derivatively liabilities.

-13-

Liquidity and Capital Resources

As at March 31, 2014, the Company's cash balance was $6,812 compared to cash balance of $3,371 as at December 31, 2013. As at March 31, 2014, the Company's total assets were $10,191 compared to total assets of $3,371 as at December 31, 2013. The increase in the cash balance and total assets was attributed to the proceeds of the convertible debenture received on February 18, 2014.

As at March 31, 2014, the Company had total liabilities of $1,104,193 compared with total liabilities of $946,300 as at December 31, 2013. The increase in total liabilities is attributed to an increase of account payable and accrued liabilities of $106,900, $68,303 of which pertained to trade accounts payable and $38,597 pertained to related party accounts payable and accrued liabilities as well as an increase in convertible debentures of $6,241 and derivative liabilities of $44,752.

As at March 31, 2014, the Company has a working capital deficit of $1,091,068 compared with working capital deficit of $938,532 at December 31, 2013 with the increase in the working capital deficit attributed to the increases in accounts payable and accrued liabilities, convertible debentures and derivative liabilities during the period as discussed above.

Cashflow from Operating Activities

During the three months ended March 31, 2014, the Company used $12,759 of cash for operating activities compared to the use of $12,726 of cash for operating activities during the three months ended March 31, 2013.  The level of cash used for operating activities was consistent compared with the prior year.

Cashflow from Financing Activities

During the three months ended March 31, 2014, the Company received $16,200 of proceeds from financing activities compared to $76 during the three months ended March 31, 2013. The increase in proceeds from financing activities was due to the Company receiving proceeds of $15,000 for the issuance of a convertible debenture and $1,200 from a related party compared to  the prior year  amount of $76 which related to the Company carrying a bank overdraft.

Subsequent Developments

None

Going Concern

We have not attained profitable operations and are dependent upon the continued financial support from our shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from our future business. These factors raise substantial doubt regarding our ability to continue as a going concern.

Off-Balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Future Financings

We will continue to rely on equity sales of our common shares in order to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund our operations and other activities.

Critical Accounting Policies

Our consolidated financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.

-14-

We regularly evaluate the accounting policies and estimates that we use to prepare our consolidated financial statements. A complete summary of these policies is included in the notes to our consolidated financial statements. In general, management's estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management.

Recently Issued Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 4.CONTROLS AND PROCEDURES.

Under the supervision and with the participation of our management, including the Principal Executive Officer and Principal Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based on that evaluation, the Principal Executive Officer and Principal Financial Officer have concluded that these disclosure controls and procedures are not effective due to the material weaknesses resulting from the Board of Directors not currently having any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K, and controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Please refer to our Annual Report on Form 10-K as filed with the SEC on April 7, 2014, for a complete discussion relating to the foregoing evaluation of Disclosures and Procedures.

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1A.RISK FACTORS.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

-15-

ITEM 6.EXHIBITS.

Exhibit		Incorporated by reference			Filed
Number	Description of Exhibit	Form	Date	Number	herewith
3.1	Articles of Incorporation.	S-1	3/24/09	3.1
3.2	Bylaws.	S-1	3/24/09	3.2
3.3	Amended and Restated Articles of Incorporation.	8-K	6/14/11	3.1a
3.4	Amended and Restated Articles of Incorporation.	8-K	8/17/11	3.1
10.1	Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.	10-K	4/07/10	10.1
10.2	Promissory Note issued to Newton Management Ltd. dated September 28, 2010.	8-K	10/08/10	10.1
10.3	Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.	8-K	11/10/10	10.1
10.4	Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.	10-Q	11/15/10	10.3
10.5	Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.	8-K	5/16/11	10.1
10.6	Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.	8-K	6/29/11	10.1
10.7	Promissory Note to Serik Enterprises, Inc.	8-K	8/12/11	10.1
10.8	Settlement Agreement with Vail International Ltd.	8-K	8/12/11	10.2
10.9	Settlement Agreement with Newton Management Ltd.	8-K	8/12/11	10.3
10.10	Settlement Agreement with Mark Simon.	8-K	8/12/11	10.4
10.11	Settlement Agreement with Carrillo Huettel, LLC.	8-K	8/12/11	10.5
10.12	Asset Acquisition Agreement.	8-K	8/17/11	10.1
10.13	Promissory Note with Hillwinds Ocean Energy, LLC.	8-K	8/17/11	10.2
10.14	Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.	10-Q	11/21/11	10.14
10.15	Draw Down Convertible Promissory Note.	10-Q	11/21/11	10.15
10.16	Intellectual Property License Agreement with Hillwinds Energy Development Corporation.	10-K	4/16/12	10.1
10.17	Exclusivity and Feasibility Study Agreement with City of Saint John.	8-K	12/05/12	10.1
10.18	Intellectual Property License Agreement with Hillwinds Energy Development Corporation dated December 10, 2012.	8-K	12/12/12	10.1
10.19	Consulting Agreement with The Holden Group.	8-K	1/03/13	10.1
10.20	Restructuring Agreement with Dennis Holden.	8-K/A	2/14/13	10.1
10.21	Restructuring Agreement with Stephen Walker.	8-K/A	2/14/13	10.2
10.22	Restructuring Agreement with Lance Warren.	8-K/A	2/14/13	10.3
14.1	Code of Ethics.	10-K	3/29/11	14.1
21.1	List of subsidiaries	S-1/A-1	1/17/13	21.1
31.1	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
32.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
99.1	Subscription Agreement.	S-1/A-1	1/17/13	99.1
101.INS	XBRL Instance Document.				X
101.SCH	XBRL Taxonomy Extension – Schema.				X
101.CAL	XBRL Taxonomy Extension – Calculations.				X
101.LAB	XBRL Taxonomy Extension – Labels.				X
101.PRE	XBRL Taxonomy Extension – Presentation.				X
101.DEF	XBRL Taxonomy Extension – Definition.				X

-16-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following person on behalf of the Registrant and in the capacities on this 14^th day of May, 2014.

HDS INTERNATIONAL CORP.
(the "Registrant")
BY:	TASSOS RECACHINAS
	Tassos Recachinas
	President, Principal Executive Officer, Principal Accounting Officer, Principal Financial Officer

-17-

EXHIBIT INDEX

Exhibit		Incorporated by reference			Filed
Number	Description of Exhibit	Form	Date	Number	herewith
3.1	Articles of Incorporation.	S-1	3/24/09	3.1
3.2	Bylaws.	S-1	3/24/09	3.2
3.3	Amended and Restated Articles of Incorporation.	8-K	6/14/11	3.1a
3.4	Amended and Restated Articles of Incorporation.	8-K	8/17/11	3.1
10.1	Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.	10-K	4/07/10	10.1
10.2	Promissory Note issued to Newton Management Ltd. dated September 28, 2010.	8-K	10/08/10	10.1
10.3	Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.	8-K	11/10/10	10.1
10.4	Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.	10-Q	11/15/10	10.3
10.5	Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.	8-K	5/16/11	10.1
10.6	Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.	8-K	6/29/11	10.1
10.7	Promissory Note to Serik Enterprises, Inc.	8-K	8/12/11	10.1
10.8	Settlement Agreement with Vail International Ltd.	8-K	8/12/11	10.2
10.9	Settlement Agreement with Newton Management Ltd.	8-K	8/12/11	10.3
10.10	Settlement Agreement with Mark Simon.	8-K	8/12/11	10.4
10.11	Settlement Agreement with Carrillo Huettel, LLC.	8-K	8/12/11	10.5
10.12	Asset Acquisition Agreement.	8-K	8/17/11	10.1
10.13	Promissory Note with Hillwinds Ocean Energy, LLC.	8-K	8/17/11	10.2
10.14	Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.	10-Q	11/21/11	10.14
10.15	Draw Down Convertible Promissory Note.	10-Q	11/21/11	10.15
10.16	Intellectual Property License Agreement with Hillwinds Energy Development Corporation.	10-K	4/16/12	10.1
10.17	Exclusivity and Feasibility Study Agreement with City of Saint John.	8-K	12/05/12	10.1
10.18	Intellectual Property License Agreement with Hillwinds Energy Development Corporation dated December 10, 2012.	8-K	12/12/12	10.1
10.19	Consulting Agreement with The Holden Group.	8-K	1/03/13	10.1
10.20	Restructuring Agreement with Dennis Holden.	8-K/A	2/14/13	10.1
10.21	Restructuring Agreement with Stephen Walker.	8-K/A	2/14/13	10.2
10.22	Restructuring Agreement with Lance Warren.	8-K/A	2/14/13	10.3
14.1	Code of Ethics.	10-K	3/29/11	14.1
21.1	List of subsidiaries	S-1/A-1	1/17/13	21.1
31.1	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
32.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
99.1	Subscription Agreement.	S-1/A-1	1/17/13	99.1
101.INS	XBRL Instance Document.				X
101.SCH	XBRL Taxonomy Extension – Schema.				X
101.CAL	XBRL Taxonomy Extension – Calculations.				X
101.LAB	XBRL Taxonomy Extension – Labels.				X
101.PRE	XBRL Taxonomy Extension – Presentation.				X
101.DEF	XBRL Taxonomy Extension – Definition.				X

-18-

EX-31.1

Exhibit 31.1

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

I, Tassos Recachinas, certify that:

1. I have reviewed this Form 10-Q for the period ended March 31, 2014 of HDS International Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and,

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 14, 2014	TASSOS RECACHINAS
		Tassos Recachinas
		Principal Executive Officer and Principal Financial Officer

EX-32

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HDS International Corp. (the "Company") on Form 10-Q for the period ended March 31, 2014 as filed with the Securities and Exchange Commission on the date here of (the "report"), I, Tassos Recachinas, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 14^th day of May, 2014.

TASSOS RECACHINAS

Tassos Recachinas

Chief Executive Officer and Chief Financial Officer

XML

4. Derivative Liabilities

3 Months Ended

Mar. 31, 2014

Disclosure Text Block [Abstract]

Derivatives and Fair Value [Text Block]

4.      Derivative Liabilities

The Company records the fair value of the of the conversion price of the convertible debentures disclosed in Notes 3(a) and 3(b) in accordance with ASC 815, Derivatives and Hedging. The fair value of the derivative was calculated using a multi-nominal lattice model performed by an independent qualified business valuator. The fair value of the derivative liability is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statement of operations. During the period ended March 31, 2014, the Company recorded a loss on the change in fair value of derivative liability of $44,752 (December, 31, 2013 - $45,521). As at March 31, 2014, the Company recorded a derivative liability of $90,273 (December, 31, 2013 - $45,521).

The following inputs and assumptions were used to value the convertible debentures outstanding during the period ended March 31, 2014:

 · The underlying stock price of $0.0014 was used as the fair value of the common stock as at December 31, 2013.

 · The underlying stock price of $0.0033 was used as the fair value of the common stock as at March 31, 2014.

 · The principal of the debenture on the June 7, 2013 date of issuance was $32,500.

 · The balance of the principal and interest of the June 7, 2013 debenture on December 4, 2013, the date the June 7, 2013 debenture became convertible, was $33,775.

 · The balance of the principal and interest of the June 7, 2013 debenture on December 31, 2013 was $33,975.

 · The balance of the principal and interest of the June 7, 2013 debenture on March 31, 2014 was $34,616.

 · The principal of the debenture on the July 15, 2013 date of issuance was $27,500.

 · The balance of the principal and interest of the July 15, 2013 debenture on January 11, 2014, the date the July 15, 2013 debenture became convertible, was $28,579.

 · The balance of the principal and interest of the July 15, 2013 debenture on March 31, 2014 was $29,061

 · Capital raising events are not a factor for the debenture.

 · The Holder would redeem based on availability of alternative financing 0% of the time increasing 1.0% monthly to a maximum of 10%.

 · The Holder would automatically convert the note at maturity if the registration (after 120 days) was effective and the Company is not in default.

 · The projected annual volatility for each valuation period was based on the historic volatility of the Company of 178% as at December 4, 2013, 176% as at December 31, 2013, 175% as at January 11, 2014 and 171% as at March 31, 2014

 · An event of default would occur 0% of the time, increasing to 1.0% per month to a maximum of 5%. To date, the debenture is not in default nor converted by the Holder.

A summary of the activity of the derivative liability is shown below:

	$
Balance, December 31, 2012		–
Derivative loss due to new issuances		46,532
Mark to market adjustment at December 31, 2013		(1,011	)
Balance, December 31, 2013		45,521
Derivative loss due to new issuances		36,272
Mark to market adjustment at March 31, 2014		8,480
Balance, March 31, 2014		90,273

XML

3. Convertible Debentures

3 Months Ended

Mar. 31, 2014

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

3.      Convertible Debentures

a)	On June 7, 2013, the Company entered into a $32,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on December 7, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (December 4, 2013) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company’s common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2014, the Company recorded accrued interest of $2,116 (December, 31, 2013 - $1,475), which has been included in accounts payable and accrued liabilities.
	In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $32,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2014, the Company had amortized $2,947 (December, 31, 2013 - $4,116) of the debt discount to interest expense. As at March 31, 2014, the carrying value of the debenture was $7,063 (December, 31, 2013 - $4,116).
	On December 4, 2013, the note became convertible resulting in the Company recording a derivative liability of $46,532 with a corresponding adjustment to loss on change in fair value of derivative liabilities. As at March 31, 2014, the Company revalued the derivative liability to its fair value resulting in the Company recording $3,504 (December 31, 2013 - $1,011) as gain on change in fair value of derivative liabilities. As at March 31, 2014, the fair value of the derivative liability was $49,025 (December, 31, 2013 - $45,521). Refer to Note 4.

b) On July 15, 2013, the Company entered into a $27,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on January 11, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (January 11, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company’s common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2014, the Company recorded accrued interest of $1,561 (December, 31, 2013 - $1,019), which has been included in accounts payable and accrued liabilities.

In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $27,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2014, the Company had amortized $1,978 (December, 31, 2013 - $2,779) of the debt discount to interest expense. As at March 31, 2014, the carrying value of the debenture was $4,757 (December, 31, 2013 - $2,779).

On January 11, 2014, the note became convertible resulting in the Company recording a derivative liability of $36,272 with a corresponding adjustment to loss on change in fair value of derivative liabilities. As at March 31, 2014, the Company revalued the derivative liability to its fair value resulting in the Company recording $4,976 (December 31, 2013 - $nil) as gain on change in fair value of derivative liabilities. As at March 31, 2014, the fair value of the derivative liability was $41,248 (December, 31, 2013 - $nil). Refer to Note 4.

c) On October 4, 2013, the Company entered into a $32,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on July 8, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (April 2, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company’s common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2014, the Company recorded accrued interest of $1,268 (December, 31, 2013 - $627), which has been included in accounts payable and accrued liabilities.

In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $32,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2014, the Company had amortized $1,024 (December, 31, 2013 - $1,618) of the debt discount to interest expense. As at March 31, 2014, the carrying value of the debenture was $2,642 (December, 31, 2013 - $1,618)

As the note does not become convertible until April 2, 2014, the Company has not yet recognized any derivative liability associated with this note.

d) On February 18, 2014, the Company entered into a $15,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and matures on August 20, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (August 17, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company’s common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2014, the Company recorded accrued interest of $139 (December, 31, 2013 - $nil), which has been included in accounts payable and accrued liabilities.

In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $15,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2014, the Company had amortized $292 (December, 31, 2013 - $nil) of the debt discount to interest expense. As at March 31, 2014, the carrying value of the debenture was $292 (December, 31, 2013 - $nil).

As the note does not become convertible until August 17, 2014, the Company has not yet recognized any derivative liability associated with this note.

XML

Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current Assets
Cash	$ 6,812	$ 3,371
Current portion of deferred financing costs	3,379
Total Current Assets	10,191	3,371
Other Assets
Deferred financing costs	2,269	6,685
Total Assets	12,460	10,056
Current Liabilities
Accounts payable and accrued liabilities	517,325	449,022
Accounts payable and accrued liabilities – related parties	181,841	143,244
Due to related parties	300,000	300,000
Convertible debentures, net of unamortized discount of $48,180 and $28,384, respectively	11,820	4,116
Derivative liability	90,273	45,521
Total Current Liabilities	1,101,259	941,903
Non-Current Liabilities
Convertible debentures, net of unamortized discount of $45,066 and $55,603, respectively	2,934	4,397
Total Liabilities	1,104,193	946,300
Class A Preferred Stock Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share Issued and outstanding: 7,500,000 shares	7,500	7,500
Common Stock Authorized: 2,000,000,000 common shares, with a par value of $0.001 per share Issued and outstanding: 377,203,075 shares	377,203	377,203
Additional paid-in capital	397,275	381,775
Deficit accumulated during the development stage	(1,873,711)	(1,702,722)
Total Stockholders’ Deficit	(1,091,733)	(936,244)
.
Total Liabilities and Stockholders’ Deficit	$ 12,460	$ 10,056

XML

1. Nature of Operations and Continuance of Business

3 Months Ended

Mar. 31, 2014

Natureof Operationand Continuanceof Business [Abstract]

Natureof Operationand Continuanceof Business

1.      Nature of Operations and Continuance of Business

HDS International Corp. (the “Company”) was incorporated on November 3, 2008 under the laws of the State of Nevada. The Company plans to engage in the business of providing renewable energy and eco-sustainability solutions based on its licensed technologies. A substantial portion of the Company’s activities has involved developing a business plan and establishing contacts and visibility in the marketplace and the Company has not generated any revenue to date.  

On June 11, 2012, HDS Energy and Ecosystems NB, Ltd., the Company’s wholly owned subsidiary, was incorporated in the Province of New Brunswick, Canada to manage the operations and other business development efforts.

Going Concern

These consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has generated no revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future.  As of March 31, 2014, the Company had a working capital deficiency of $1,091,068 and an accumulated deficit of $1,873,711. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. 

XML

6. Commitments (Details) (USD $)	3 Months Ended			12 Months Ended		65 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2014	Jan. 31, 2014	Oct. 01, 2012	Jul. 18, 2012	Jun. 10, 2012	Oct. 12, 2011
Disclosure Text Block Supplement [Abstract]
Contractual Obligation One											$ 3,000
Contractual Obligation One First Revision									3,750
Contractual Obligation One Second Revision								3,000
Contractual Obligation One, Third Revision							500
Professional and Contract Services Expense	96,000		111,750	36,000	1,500	1,108,750
Contractual Obligation One Account Payable	43,500			42,000		43,500
Contractual Obligation Two											27,500
Contractual Obligation Two, First Revision							21,500
Contractual Obligation Two, Professional and Contract Fee Expense	64,500			330,000
Contractual Obligation Two Account Payable	448,000			383,500		448,000
Contractual Obligation Three											3,000
Contractual Obligation Three First Revision										6,000
Contractual Obligation Three Second Revision									3,750
Contractual Obligation Three, Third Revision							10,000
Contractual Obligation, Three Professional and Contract Fee Expense	30,000			45,000
Contractual Obligation Three Account Payable	90,000			60,000		90,000
Contractual Obligation		2,000	2,000
Stock Issued During Period, Shares, Issued for Services (in Shares)		600,000
Contractual Obligation, Due in Next Twelve Months		$ 500	$ 500

XML

2. Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

2.      Summary of Significant Accounting Policies

a)       Principles of Consolidation

The consolidated financial statements financial statements for the periods ended March 31, 2014 and December 31, 2013 include the accounts of HDS International Corp. and HDS Energy and Ecosystems NB, Ltd., the Company’s wholly owned subsidiary effective June 11, 2012. All intercompany transactions have been eliminated in consolidation.

b)       Basis of Presentation

These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in US dollars. The Company’s fiscal year-end is December 31.

c)       Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States and requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to stock-based compensation and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

d)       Cash and Cash Equivalents

The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. As of March 31, 2014 and December 31, 2013, the Company had no cash equivalents.

e)       Intangible Assets

Intangible assets are carried at the purchased cost less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets, generally from fifteen to twenty years.

f)        Impairment of Long-Lived Assets

Long-lived assets and certain identifiable intangible assets to be held and used are reviewed for impairment whenever events or changes in circumstance indicate that the carrying amount of such assets may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. Measurement of an impairment loss for long-lived assets and certain identifiable intangible assets that management expects to hold and use is based on the fair value of the asset. Long-lived assets and certain identifiable intangible assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

g)       Beneficial Conversion Features

From time to time, the Company may issue convertible notes that may contain an imbedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.

h)       Derivative Liability

From time to time, the Company may issue equity instruments that may contain an embedded derivative instrument which may result in a derivative liability. A derivative liability exists on the date the equity instrument is issued when there is a contingent exercise provision. The derivative liability is records at is fair value calculated by using an option pricing model such as a multi-nominal lattice model. The fair value of the derivative liability is then calculated on each balance sheet date with the corresponding gains and losses recorded in the consolidated statement of operations

i)        Development Stage Company

The Company is currently considered a development stage company as defined by ASC 915-10-05. As a development stage enterprise, the Company discloses the deficit accumulated during the development stage and the cumulative statements of operations and cash flows from inception to the current balance sheet date. An entity remains in the development stage until such time as, among other factors, revenues have been realized. To date, the development stage of the Company’s operations consists of developing the business model and marketing concepts.

j)        Basic and Diluted Net Loss Per Share

The Company computes net loss per share in accordance with ASC 260, Earnings Per Share, which requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. At March 31, 2013, the Company had 95,238,095 (December 31, 2013 – 51,166,667) potentially dilutive shares from outstanding convertible debentures.

k)       Interim Consolidated Financial Statements

These interim unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period.

l)        Income Taxes

Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740, Income Taxes, as of its inception. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.

m)      Comprehensive Loss

ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at March 31, 2014 and December 31, 2013, the Company has no items that represent comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements.

n)       Financial Instruments

ASC 820, “Fair Value Measurements”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Assets and liabilities measured at fair value on a recurring basis were presented on the Company’s balance sheet as at March 31, 2014 and December 31, 2013 as follows:

	Balance, December 31, 2013 $		New Issuances $		Changes in Fair Values $			Balance, March 31, 2014 $
Convertible debenture		8,513		15,500		(9,259	)		14,754
Derivative Liability		45,521		–		44,752			90,273
		54,034		15,500		35,493			105,027

The carrying values of all of our other financial instruments, which include accounts payable and accrued liabilities, and amounts due to related parties approximate their current fair values because of their nature and respective maturity dates or durations.

o)       Recent Accounting Pronouncements

In July 2013, FASB issued ASU No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists." The provisions of ASU No. 2013-11 require an entity to present an unrecognized tax benefit, or portion thereof, in the statement of financial position as a reduction to a deferred tax asset for a net operating loss carryforward or a tax credit carryforward, with certain exceptions related to availability. ASU No. 2013 11 is effective for interim and annual reporting periods beginning after December 15, 2013. The adoption of ASU No. 2013-11 did not have a material impact on the Company's consolidated financial statementsIn August 2012, the FASB issued ASU 2012-03, "Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update)" in Accounting Standards Update No. 2012-03. This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 is not expected to have a material impact on our financial position or results of operations.

The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). The amendments are effective for reporting periods beginning after December 15, 2012, for public companies. Early adoption is permitted. The adoption of ASU No. 2013-02 did not have a material impact on the Company’s consolidated financial statements.

In January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like ASU 2011-11, the amendments in this update will be effective for fiscal periods beginning on, or after January 1, 2013. The adoption of ASU 2013-01 did not have a material impact on the Company’s consolidated financial statements.

The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

XML

Balance Sheets (Parentheticals) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Preferred stock, authorized	25,000,000	25,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Class A Preferred Stock, authorized	$ 25,000,000	$ 25,000,000
Class A Preferred stock, par value	0.001	0.001
Class A Preferred stock, issued	7,500,000	7,500,000
Class A Preferred stock, outstanding	$ 7,500,000	$ 7,500,000
Common Stock, authorized	2,000,000,000	2,000,000,000
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, issued	377,203,075	377,203,075
Common Stock, outstanding	377,203,075	377,203,075

XML

2. Summary of Significant Accounting Policies (Details) - Assets and Liabilities Measured at Fair Value (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Assets and Liabilities Measured at Fair Value [Abstract]
Convertible debenture	$ 14,754	$ 8,513
Derivative Liability	90,273	45,521
	105,027	54,034
	$ 105,027	$ 54,034

XML

Document And Entity Information (USD $)	3 Months Ended
	Mar. 31, 2014	May 01, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	HDS International Corp.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		385,774,504
Entity Public Float		$ 0
Amendment Flag	false
Entity Central Index Key	0001454742
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1

XML

3. Convertible Debentures (Details) (USD $)	1 Months Ended		3 Months Ended									6 Months Ended	7 Months Ended	10 Months Ended	12 Months Ended		65 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 30, 2014	Mar. 31, 2014	Mar. 29, 2014	Mar. 30, 2014	Mar. 31, 2014	Dec. 30, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Mar. 31, 2014	Dec. 30, 2013	Dec. 31, 2013	Mar. 31, 2014	Mar. 28, 2014	Dec. 29, 2013	Sep. 30, 2013	Jun. 30, 2013	Jun. 08, 2013
Debt Disclosure [Abstract]
Debt Instrument, Face Amount	$ 15,500	$ 32,500	$ 15,500	$ 15,500		$ 15,500			$ 15,500		$ 32,500	$ 32,500	$ 32,500	$ 15,500		$ 32,500	$ 15,500			$ 27,500	$ 32,500	$ 32,500
Debt Instrument, Interest Rate, Effective Percentage		8.00%								8.00%	8.00%	8.00%	8.00%		8.00%	8.00%				8.00%	8.00%
Debt Instrument, Convertible, Conversion Ratio	0.50										0.50	0.50		0.50
Debt Instrument, Convertible, Interest Expense	139			1,268		1,561			2,116		627	1,019				1,475
Debt Instrument, Convertible, Beneficial Conversion Feature	15,500								8,480	32,500		27,500	32,500			(1,011)
Amortization of Debt Discount (Premium)	292				1,024	1,978		2,947	15,500			2,779			1,618	4,116	108,000
Debt Instrument, Convertible, Carrying Amount of Equity Component	7,063	4,116	7,063	7,063	292	7,063	2,642	292	7,063	1,618	4,116	4,116	4,116	7,063	1,618	4,116	7,063	4,757	2,779
Derivative, Loss on Derivative		46,532	36,272						36,272							46,532
Derivative, Gain on Derivative							4,976		3,504							1,011
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net						$ 41,248		$ 49,025	$ (44,752)							$ 45,521	$ (90,273)

XML

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		65 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Consulting fees	$ 96,000	$ 111,750	$ 1,108,750
General and administrative	1,760	2,661	105,610
Management fees			43,727
Professional fees	11,100	9,500	238,601
Transfer agent fees		169	18,868
Total Operating Expenses	108,860	124,080	1,515,556
Loss Before Other Expenses	(108,860)	(124,080)	(1,515,556)
Other Expenses
Accretion expense			16,800
Impairment of intangible assets			92,538
Interest expense	17,377	7,397	139,626
Loss on change in fair value of derivative liability	44,752		90,273
Loss on settlement of debt			18,918
Total Other Expenses	62,129	7,397	358,155
Net Loss	$ (170,989)	$ (131,477)	$ (1,873,711)
Net Loss Per Share, Basic and Diluted (in Dollars per share)	$ 0.00	$ 0.00
Weighted Average Shares Outstanding (in Shares)	377,203,075	377,189,745

XML

7. Subsequent Event

3 Months Ended

Mar. 31, 2014

Subsequent Events [Abstract]

Subsequent Events [Text Block]

7.      Subsequent Event

On April 9, 2014, the Company issued 8,571,429 common shares for the conversion of $12,000 of the convertible debenture, as noted in Note 3(a).

XML

6. Commitments

3 Months Ended

Mar. 31, 2014

Disclosure Text Block Supplement [Abstract]

Commitments Disclosure [Text Block]

6.      Commitments

a) On October 12, 2011, the Company entered into a verbal consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On July 18, 2012, the Board of Directors reviewed the consulting agreement and authorized an increase to the monthly consulting fee from $3,000 to $3,750 per month beginning July 2012. On October 1, 2012, the Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,750 to $3,000 per month beginning October 2012. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,000 to $500 per month effective January 1, 2014.

During the period ended March 31, 2014, the Company incurred $1,500 (December 31, 2013 - $36,000) in consulting fees relating to this agreement, of which $43,500 (December 31, 2013 - $42,000) has been recorded in accounts payable and accrued liabilities as at March 31, 2014.

b) On October 12, 2011, the Company entered into a consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $27,500. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $27,500 to $21,500 per month effective January 1, 2014.

During the year ended March 31, 2014, the Company incurred $64,500 (December 31, 2013 - $330,000) in consulting fees relating to this agreement, of which $448,000 (December 31, 2013 - $383,500) has been recorded in accounts payable and accrued liabilities as at March 31, 2014.

c) On October 12, 2011, the Company entered into a consulting agreement with the President and CEO of the Company whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On June 10, 2012, the Board of Directors authorized an increase to the monthly consulting fee from $3,000 to $6,000 per month beginning June 2012. On July 18, 2012, the Board of Directors reviewed the consulting agreement and adjusted the monthly consulting fee to $3,750 beginning July 2012. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,750 to $10,000 per month effective January 1, 2014.

During the year ended March 31, 2014, the Company incurred $30,000 (December 31, 2013 - $45,000) in consulting fees relating to this agreement, of which $90,000 (December 31, 2013 - $60,000) has been recorded in accounts payable and accrued liabilities – related parties as at March 31, 2014.

d) On January 2, 2013, the Company entered into a consulting agreement with The Holden Group, LLC (“Holden”) whereby the Company paid Holden $2,000 and issued 600,000 restricted common shares of the Company upon the execution of the agreement as well as pay $500 on each of the first, second and third month anniversaries of the agreement. These final three payments have been accrued and recorded in accounts payable and accrued liabilities.

XML

7. Subsequent Event (Details) (USD $)	0 Months Ended
	Apr. 09, 2014
Subsequent Events [Abstract]
Stock Issued During Period, Shares, Conversion of Convertible Securities	8,571,429
Stock Issued During Period, Value, Conversion of Convertible Securities	$ 12,000

XML

4. Derivative Liabilities (Details) (USD $)	1 Months Ended	0 Months Ended	3 Months Ended		6 Months Ended	9 Months Ended
	Dec. 31, 2013	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Sep. 30, 2013	Jul. 16, 2013	Jun. 08, 2013
Disclosure Text Block [Abstract]
Derivative Liability, Fair Value, Net (in Dollars)	$ 45,521		$ 44,752	$ 44,752	$ 45,521	$ 44,752
Derivative Liabilities (in Dollars)	45,521		90,273	90,273	45,521	90,273
Share Price (in Dollars per share)	$ 0.0014		$ 0.0033	$ 0.0033	$ 0.0014	$ 0.0033
Debt Instrument, Face Amount (in Dollars)	32,500	32,500	15,500	15,500	32,500	15,500	27,500		32,500
Derivative Liabilities, Current (in Dollars)	$ 33,975		$ 34,616	$ 34,616	$ 33,975	$ 34,616		$ 27,500	$ 33,775
Debt Instrument, Convertible, Effective Interest Rate		28579.00%				29061.00%
Fair Value Assumptions, Risk Free Interest Rate			10.00%	1.00%	0.00%
Fair Value Assumptions, Expected Volatility Rate	178.00%		171.00%	175.00%
Fair Value Inputs, Probability of Default			5.00%	1.00%	0.00%

XML

1. Nature of Operations and Continuance of Business (Details) (USD $)	Mar. 31, 2014
Natureof Operationand Continuanceof Business [Abstract]
Working Capital Deficit	$ 1,091,068
Cumulative Earnings (Deficit)	$ 1,873,711

XML

2. Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Fair Value, Assets Measured on Recurring Basis [Table Text Block]

	Balance, December 31, 2013 $		New Issuances $		Changes in Fair Values $			Balance, March 31, 2014 $
Convertible debenture		8,513		15,500		(9,259	)		14,754
Derivative Liability		45,521		–		44,752			90,273
		54,034		15,500		35,493			105,027

XML

4. Derivative Liabilities (Tables)

3 Months Ended

Mar. 31, 2014

Disclosure Text Block [Abstract]

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]

	$
Balance, December 31, 2012		–
Derivative loss due to new issuances		46,532
Mark to market adjustment at December 31, 2013		(1,011	)
Balance, December 31, 2013		45,521
Derivative loss due to new issuances		36,272
Mark to market adjustment at March 31, 2014		8,480
Balance, March 31, 2014		90,273

XML

2. Summary of Significant Accounting Policies (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	95,238,095	51,166,667

XML

5. Related Party Transactions (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 30, 2013	Dec. 31, 2012
Related Party Transactions [Abstract]
Related Party Transaction, Due from (to) Related Party	$ 300,000			$ 300,000
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Interest Payable	79,616	72,219
Due to Related Parties	10,225	10,225
Due to Officers or Stockholders, Current	30,000	45,000
Accounts Payable and Accrued Liabilities - Other Related Party	90,000	60,000
Accounts Payable, Related Parties	2,000
	$ 181,841	$ 143,244	$ 800

XML

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended		65 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Net loss	$ (170,989)	$ (131,477)	$ (1,873,711)
Adjustment to reconcile net loss to net cash used in operating activities:
Accretion of debt discount	6,241		31,554
Amortization of deferred financing costs	1,537		4,352
Impairment of intangible assets			92,538
Loss on change in fair value of derivative liability	(44,752)		(90,273)
Loss on settlement of debt			18,918
Shares issued for management and consulting fees		6,000	13,000
Stock-based compensation			2,227
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	68,303	81,154	564,932
Accounts payable and accrued liabilities – related parties	37,397	31,597	169,616
Due to related parties			11,965
Net Cash Used in Operating Activities	(12,759)	(12,726)	(874,336)
Investing activities
Acquisition of intangible assets			(10,000)
Net Cash Used by Investing Activities			(10,000)
Financing activities
Bank overdraft		76
Proceeds from convertible debenture, net of financing costs	15,000		98,000
Proceeds from loan payable			709,600
Repayments of loan payable			(149,449)
Proceeds from related parties	1,200		14,874
Repayments to related parties			(25,000)
Capital contribution			200,600
Proceeds from the issuance of common stock			42,523
Net Cash Provided by Financing Activities	16,200	76	891,148
Change in Cash	3,441	(12,650)	6,812
Cash, Beginning of Period	3,371	12,650
Cash, End of Period	6,812		6,812
Non-cash investing and financing activities
Debt discount due to beneficial conversion feature	15,500		108,000
Forgiveness of related party debt			2,649
Issuance of common shares to settle debt			580,055
Issuance of common shares for acquisition of assets			250,000
Issuance of preferred shares for acquisition of assets			7,500
Issuance of note payable for acquisition of assets			$ 325,000

XML

5. Related Party Transactions

3 Months Ended

Mar. 31, 2014

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

5.      Related Party Transactions

a) As at March 31, 2014, the Company owes $300,000 (December 31, 2013 - $300,000) to a company controlled by officers and directors of the Company.  The amount owing is unsecured, bears interest at 10% per annum, and is due on demand.  As at March 31, 2014, the Company has recorded accrued interest of $79,616 (December 31, 2013 - $72,219) which has been included in accounts payable and accrued liabilities – related party.

b) As at March 31, 2014, the Company owes $10,225 (December 31, 2013 - $10,225) to companies under common control by officers and directors of the Company which has been included in accounts payable and accrued liabilities – related parties. The amounts owing are unsecured, non-interest bearing, and due on demand.

c) During the period ended March 31, 2014, the Company has incurred $30,000 (December 31, 2013 - $45,000) to the President and CEO of the Company for consulting services. As at March 31, 2014, the Company recorded a related party accounts payable of $90,000 (December 31, 2013 - $60,000), which has been included in accounts payable and accrued liabilities – related party. The amounts owing are unsecured, non-interest bearing, and due on demand.

d) As at March 31, 2014, the Company owes $2,000 (December 31, 2013 – $800) to the President and CEO of the Company for reimbursement of expenses which has been included in accounts payable and accrued liabilities – related parties.  The amount owing is unsecured, non-interest bearing, and due on demand.

XML

4. Derivative Liabilities (Details) - Summary of Derivative Liability Activity (USD $)	1 Months Ended		3 Months Ended			6 Months Ended	7 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Dec. 30, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Jul. 16, 2013	Jun. 08, 2013
Summary of Derivative Liability Activity [Abstract]
Balance				$ 33,975					$ 27,500	$ 33,775
Derivative loss due to new issuances		46,532	36,272	36,272				46,532
Mark to market adjustment	15,500			8,480	32,500	27,500	32,500	(1,011)
Balance	$ 34,616	$ 33,975	$ 34,616	$ 34,616		$ 33,975	$ 33,975	$ 33,975	$ 27,500	$ 33,775